Effects of Gender and Baseline CD4 Count on Post-Treatment CD4 Count Recovery and Outcomes in Patients with Advanced HIV Disease: A Retrospective Cohort Study
AIDS Research and Human Retroviruses · 2023
DOI: 10.1089/aid.2022.0117 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift AIDS Research and Human Retroviruses, 2023. Verfasst von Vinie Kouamou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Charles River Medical Group, Harare, Zimbabwe. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charles River Medical Group, Harare, Zimbabwe.
- Unit of Internal Medicine, Department of Primary Health Care Sciences, University of Zimbabwe, Harare, Zimbabwe.
ORCID-Profile: Vinie Kouamou
Zitieren
APA
Kouamou, V., Gundidza, P., Ndhlovu, C. E., Makadzange, A. T., & CryptoART Study Team (2023). Effects of Gender and Baseline CD4 Count on Post-Treatment CD4 Count Recovery and Outcomes in Patients with Advanced HIV Disease: A Retrospective Cohort Study. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2022.0117
Vancouver
Kouamou V, Gundidza P, Ndhlovu CE, Makadzange AT, CryptoART Study Team. Effects of Gender and Baseline CD4 Count on Post-Treatment CD4 Count Recovery and Outcomes in Patients with Advanced HIV Disease: A Retrospective Cohort Study. AIDS Research and Human Retroviruses. 2023. doi:10.1089/aid.2022.0117
BibTeX
@article{Kouamou2023,
author = {Kouamou, Vinie and Gundidza, Patricia and Ndhlovu, Chiratidzo E and Makadzange, Azure Tariro and CryptoART Study Team, CryptoART Study Team},
title = {Effects of Gender and Baseline CD4 Count on Post-Treatment CD4 Count Recovery and Outcomes in Patients with Advanced HIV Disease: A Retrospective Cohort Study},
journal = {AIDS Research and Human Retroviruses},
year = {2023},
doi = {10.1089/aid.2022.0117}
}
EUVIMED